Evidation
Founded Year
2012Stage
Series E | AliveTotal Raised
$259.18MValuation
$0000Last Raised
$153M | 5 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-95 points in the past 30 days
About Evidation
Evidation is involved in measuring health in everyday life within the digital health sector. The company provides a platform for individuals to track health activities, participate in research, and manage their data privacy. Evidation serves the life sciences, government, and non-profit organizations. It was founded in 2012 and is based in San Mateo, California.
Loading...
ESPs containing Evidation
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The digital biomarker monitoring market provides technology solutions that capture and analyze digital health data to assess and predict health outcomes. Utilizing devices and software that integrate into patients’ daily lives, these solutions monitor various physiological and behavioral indicators that serve as biomarkers for health conditions. This market includes mobile apps that track activity…
Evidation named as Outperformer among 15 other companies, including Amazon, Medidata, and Oura.
Evidation's Products & Differentiators
Research
Evidation runs programs for enterprises to get actionable evidence in three areas: disease burden and patient impact, patient segmentation and identification, disease event and progression modelling. We deploy a proven approach, incorporating our experience with over 200 research programs, to reliably delivers results. Given our connectivity with highly engaged individuals, we deliver faster and more cost-effectively.
Loading...
Research containing Evidation
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Evidation in 5 CB Insights research briefs, most recently on Aug 21, 2024.
Expert Collections containing Evidation
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Evidation is included in 6 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,297 items
Digital Health 50
300 items
The most promising digital health startups transforming the healthcare industry
Value-Based Care & Population Health
1,262 items
The VBC & Population Health collection includes companies that enable and deliver care models that address the health needs for defining populations along the continuum of care, including in the community setting, through participation, engagement, and targeted interventions.
Digital Health
12,122 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,123 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Precision Medicine Tech Market Map
160 items
This CB Insights Tech Market Map highlights 160 precision medicine companies that are addressing 9 distinct technology priorities that pharmaceutical companies and healthcare providers face.
Evidation Patents
Evidation has filed 12 patents.
The 3 most popular patent topics include:
- machine learning
- wearable devices
- epidemiology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/18/2022 | 11/12/2024 | Sleep disorders, Machine learning, Health informatics, Circadian rhythm, Psychiatric diagnosis | Grant |
Application Date | 10/18/2022 |
|---|---|
Grant Date | 11/12/2024 |
Title | |
Related Topics | Sleep disorders, Machine learning, Health informatics, Circadian rhythm, Psychiatric diagnosis |
Status | Grant |
Latest Evidation News
Sep 1, 2025
Search jobs 01-Sep-2025 Digital Biomarkers Global Markets Report 2025-2030 with Profiles of Leading Players - Actigraph, AliveCor, Altoida, Evidation Health, and IXICO - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)--The "Digital Biomarkers: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030. This report provides an overview of the global market for digital biomarkers and analyzes market trends. It includes global revenue ($ millions) for the base year data of 2024, estimates for 2025 and projections of compound annual growth rates (CAGRs) from 2025 through 2030. The market is segmented based on system components, applications, therapeutic areas, end users and regions. The regions covered in this study include North America, Europe, Asia-Pacific and the Rest of the World (RoW), focusing on major countries in these regions. The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and governance (ESG) developments and discusses emerging technologies related to the market. The report includes: An overview of the global market for digital biomarkers Estimation of the market size and analyses of global market trends, with data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030 Information regarding major market drivers, opportunities and challenges, industry chain structure, distribution channel and technological advancements that are affecting the overall market Evaluation of market potential and revenue forecast for the digital biomarkers market based on system component, application, therapeutic area, end user and region Insights into the industry structure, current competitive scenario, R&D activities, growth strategies and ESG trends of the market Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, joint ventures and strategic alliances Profiles of the leading companies, including Actigraph LLC., AliveCor Inc., Altoida, Evidation Health Inc., and IXICO Plc. Company Profiles
Evidation Frequently Asked Questions (FAQ)
When was Evidation founded?
Evidation was founded in 2012.
Where is Evidation's headquarters?
Evidation's headquarters is located at 63 Bovet Road, San Mateo.
What is Evidation's latest funding round?
Evidation's latest funding round is Series E.
How much did Evidation raise?
Evidation raised a total of $259.18M.
Who are the investors of Evidation?
Investors of Evidation include B Capital, McKesson Ventures, OMERS Private Equity, Kaiser Permanente Ventures, SV Health Investors and 16 more.
Who are Evidation's competitors?
Competitors of Evidation include ObvioHealth, Folia Health, Money Walk, MediMergent, Elfie and 7 more.
What products does Evidation offer?
Evidation's products include Research.
Loading...
Compare Evidation to Competitors
Medable specializes in the development of decentralized clinical trial software and electronic Clinical Outcome Assessment (eCOA) solutions within the healthcare technology sector. The company's platform provides tools for remote monitoring, data collection, and trial management, utilizing artificial intelligence (AI) to improve processes in clinical research. Medable serves the pharmaceutical and biotechnology industries, including mid to large pharma, emerging biotech firms, and contract research organizations (CROs). Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.
Castor operates within the healthcare sector and provides a clinical trial platform designed for the design, deployment, patient engagement, data collection, and analysis of clinical trials. The platform is adaptable and can meet the requirements of different stakeholders in the clinical research process. It primarily serves the healthcare sector. The company was founded in 2012 and is based in Amsterdam, Netherlands.
ObvioHealth provides digital health solutions within the clinical trial industry. The company has a platform and mobile application allows for remote monitoring and participation in clinical trials, focusing on data collection and participant engagement. ObvioHealth's services are relevant to the healthcare sector, especially in trial management. It was founded in 2017 and is based in New York, New York.
Bloqcube specializes in clinical trial management software within the life science industry. Its platform aggregates data in real-time and aims to assist small and midsize life-science companies. Bloqcube's services are directed towards the life science sector, focusing on clinical trials. It was founded in 2017 and is based in Piscataway, New Jersey.
Medidata specializes in providing a unified platform for clinical research within the life sciences sector. The company offers a range of products and solutions designed to streamline clinical trials, including data management, clinical operations, and patient engagement technologies. Medidata's platform serves various sectors, including biopharmacy, medical device companies, and academic research organizations. It was founded in 1999 and is based in New York, New York.
Curebase is a company that provides an eClinical platform in the clinical research sector, offering tools such as electronic patient-reported outcomes (ePRO), electronic clinical outcome assessments (eCOA), electronic consent (eConsent), and electronic data capture (EDC) systems. The platform is designed for study launches, data collection, and participant engagement. It was founded in 2017 and is based in San Francisco, California.
Loading...